Correlation Between ZimVie and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZimVie and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZimVie and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZimVie Inc and Neuropace, you can compare the effects of market volatilities on ZimVie and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZimVie with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZimVie and Neuropace.

Diversification Opportunities for ZimVie and Neuropace

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ZimVie and Neuropace is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding ZimVie Inc and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and ZimVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZimVie Inc are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of ZimVie i.e., ZimVie and Neuropace go up and down completely randomly.

Pair Corralation between ZimVie and Neuropace

Given the investment horizon of 90 days ZimVie Inc is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, ZimVie Inc is 1.88 times less risky than Neuropace. The stock trades about -0.18 of its potential returns per unit of risk. The Neuropace is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,087  in Neuropace on December 30, 2024 and sell it today you would earn a total of  98.00  from holding Neuropace or generate 9.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ZimVie Inc  vs.  Neuropace

 Performance 
       Timeline  
ZimVie Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ZimVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Neuropace 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

ZimVie and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZimVie and Neuropace

The main advantage of trading using opposite ZimVie and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZimVie position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind ZimVie Inc and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments